SCHEMBL3847708

SCHEMBL3847708

NCc1nnc(-c2cnc3ccc(-c4cn(C(c5ccccc5)(c5ccccc5)c5ccccc5)nc4-c4ccc(F)cc4)cn23)o1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIK3R1 P27986 5/20 0.37
PIK3CA P42336 5/20 0.37
PTGS2 P35354 3/20 0.36
NOTUM Q6P988 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
TGFBR1 P36897 5/20 0.33
PIK3CD O00329 1/20 0.33
PIK3CB P42338 1/20 0.33
MTOR P42345 1/20 0.33
PIK3CG P48736 1/20 0.33
MAPK14 Q16539 2/20 0.33
FLT3 P36888 1/20 0.33
AKT1 P31749 1/20 0.33
AKT2 P31751 1/20 0.33
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
TSHR P16473 1/20 0.32
HTT P42858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3849288 0.87 PTGS2 (0.37) PIK3R1PIK3CAPTGS2TGFBR1MAPK14
SCHEMBL3847230 0.85 PTGS2 (0.36) PIK3R1PIK3CAPTGS2TGFBR1MAPK14
SCHEMBL3853605 0.84 FLT3 (0.39) PIK3R1PIK3CAPTGS2NOTUMTGFBR1
SCHEMBL3850397 0.81 FLT3 (0.43) TGFBR1MAPK14FLT3AKT1AKT2
SCHEMBL3845245 0.80 FLT3 (0.39) TGFBR1MAPK14FLT3AKT1AKT2
SCHEMBL6639535 0.80 PIK3R1 (0.41) PIK3R1PIK3CANOTUMSMN1; SMN2NPC1
SCHEMBL3846734 0.80 MKNK1 (0.44) TGFBR1FLT3AKT1AKT2
SCHEMBL3845957 0.79 FLT3 (0.41) PIK3CATGFBR1FLT3AKT1AKT2
SCHEMBL3847038 0.79 FLT3 (0.38) TGFBR1MAPK14FLT3AKT1AKT2
SCHEMBL3847481 0.79 TGFBR1 (0.40) TGFBR1MAPK14FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed